Simmons Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Simmons Bank's REGN Position: Q2 2026 in Review
Simmons Bank increased its Regeneron Pharmaceuticals (REGN) stake by 8.5% in Q2 2026, buying an estimated $229K and bringing the position to 4,282 shares worth $2.67M. The position accounts for 0.15% of the portfolio, ranked #132.
Simmons Bank first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.05M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Simmons Bank held 4,282 shares of Regeneron Pharmaceuticals worth $2.67M as of Q2 2026.
- Simmons Bank bought 336 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $229K.
- Regeneron Pharmaceuticals made up 0.15% of Simmons Bank's portfolio in Q2 2026, its #132 holding.
- Simmons Bank first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Simmons Bank's Regeneron Pharmaceuticals position peaked at $3.05M in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.